Engineers Gate Manager LP Dbv Technologies S.A. Transaction History

Engineers Gate Manager LP

  • $4.27 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 17, 2020
SELL
$3.74 - $6.28 $52,360 - $87,920
-14,000 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$2.33 - $12.98 $32,620 - $181,720
14,000 New
14,000 $55,000

Others Institutions Holding DBVT

# of Institutions
4
Shares Held
253K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $124M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email